中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2011年
3期
223-227
,共5页
臧盛兵%刘景丰%王斌%高凌云%陈水平%黄爱民
臧盛兵%劉景豐%王斌%高凌雲%陳水平%黃愛民
장성병%류경봉%왕빈%고릉운%진수평%황애민
肝肿瘤%KiSS-1%KiSS-1R%MMP-9%组织芯片
肝腫瘤%KiSS-1%KiSS-1R%MMP-9%組織芯片
간종류%KiSS-1%KiSS-1R%MMP-9%조직심편
Liver neoplasm%KiSS-1%KiSS-1R%MMP-9%Tissue chip
目的 检测肿瘤转移抑制基因KiSS-1及其配体KiSS-1R和基质金属蛋白酶-9(MMP-9)在肝细胞癌(HCC)中的表达,探讨KiSS-1表达与肝细胞癌侵袭转移的关系及其机制.方法 利用逆转录聚合酶链反应(RT-PCR)技术,检测HCC、癌旁肝组织及远癌肝组织中KiSS-1、KiSS-1R mRNA的表达情况;应用HCC组织芯片,结合免疫组化及彩色图像分析技术检测了KiSS-1、MMP-9蛋白在HCC芯片中各组织的相对表达量.结果 KiSS-1 mRNA在HCC中表达明显低于癌旁、远癌肝组织(P<0.01).在转移组和临床Ⅲ期HCC中,KiSS-1蛋白的表达明显低于无转移及临床分期Ⅰ和Ⅱ期HCC(P<0.01);KiSS-1在肝内转移灶中的表达量显著低于原发灶(P<0.01).在转移组的HCC中,MMP-9表达量显著高于无转移的HCC(P<0.01).在HCC组织中,KiSS-1和MMP-9的表达呈负相关性(r=-0.340,P<0.01).结论 KiSS-1和MMP-9的表达失衡与HCC侵袭转移有关,KiSS-1的缺失表达可作为预测HCC转移潜能的有价值的参考指标.
目的 檢測腫瘤轉移抑製基因KiSS-1及其配體KiSS-1R和基質金屬蛋白酶-9(MMP-9)在肝細胞癌(HCC)中的錶達,探討KiSS-1錶達與肝細胞癌侵襲轉移的關繫及其機製.方法 利用逆轉錄聚閤酶鏈反應(RT-PCR)技術,檢測HCC、癌徬肝組織及遠癌肝組織中KiSS-1、KiSS-1R mRNA的錶達情況;應用HCC組織芯片,結閤免疫組化及綵色圖像分析技術檢測瞭KiSS-1、MMP-9蛋白在HCC芯片中各組織的相對錶達量.結果 KiSS-1 mRNA在HCC中錶達明顯低于癌徬、遠癌肝組織(P<0.01).在轉移組和臨床Ⅲ期HCC中,KiSS-1蛋白的錶達明顯低于無轉移及臨床分期Ⅰ和Ⅱ期HCC(P<0.01);KiSS-1在肝內轉移竈中的錶達量顯著低于原髮竈(P<0.01).在轉移組的HCC中,MMP-9錶達量顯著高于無轉移的HCC(P<0.01).在HCC組織中,KiSS-1和MMP-9的錶達呈負相關性(r=-0.340,P<0.01).結論 KiSS-1和MMP-9的錶達失衡與HCC侵襲轉移有關,KiSS-1的缺失錶達可作為預測HCC轉移潛能的有價值的參攷指標.
목적 검측종류전이억제기인KiSS-1급기배체KiSS-1R화기질금속단백매-9(MMP-9)재간세포암(HCC)중적표체,탐토KiSS-1표체여간세포암침습전이적관계급기궤제.방법 이용역전록취합매련반응(RT-PCR)기술,검측HCC、암방간조직급원암간조직중KiSS-1、KiSS-1R mRNA적표체정황;응용HCC조직심편,결합면역조화급채색도상분석기술검측료KiSS-1、MMP-9단백재HCC심편중각조직적상대표체량.결과 KiSS-1 mRNA재HCC중표체명현저우암방、원암간조직(P<0.01).재전이조화림상Ⅲ기HCC중,KiSS-1단백적표체명현저우무전이급림상분기Ⅰ화Ⅱ기HCC(P<0.01);KiSS-1재간내전이조중적표체량현저저우원발조(P<0.01).재전이조적HCC중,MMP-9표체량현저고우무전이적HCC(P<0.01).재HCC조직중,KiSS-1화MMP-9적표체정부상관성(r=-0.340,P<0.01).결론 KiSS-1화MMP-9적표체실형여HCC침습전이유관,KiSS-1적결실표체가작위예측HCC전이잠능적유개치적삼고지표.
Objective To detect the expression of KiSS-1, KiSS-1R and MMP-9 in hepatocellular carcinoma (HCC). To study the correlation of KiSS-1, KiSS-1R and MMP-9 expression with invasion and metastasis of HCC, and to explore the underlying mechanisms. Methods The expression of KiSS-1 , KiSS-1R mRNA in 33 HCC samples, 26 non-neoplastic adjacent liver tissue samples and 13 non-neoplastic distant liver tissue samples were detected by RT-PCR. Tissue chips were constructed by modified manual tools, which contained HCC, non-neoplastic adjacent liver tissues, non-neoplastic distant liver tissues, normal liver tissues and intrahepatic metastasis lesions. The expression of KiSS-1 and MMP-9 protein was determined by tissue chips, immunohistochemistry and semi-quantitative image analysis in 150 HCC, 137 non-neoplastic adjacent liver tissue, 98 non-neoplastic distant liver tissues, 16 normal liver tissues and 37 intrahepatic metastasis lesion samples. Results The results of RT-PCR showed that compared with the non-neoplastic adjacent liver tissues and the non-neoplastic distant liver tissues, the expression of KiSS-1 mRNA in HCC was significantly lower (P<0.01). The expression of KiSS-1R mRNA did not changed in HCC and non-neoplastic liver tissues (P>0.05). The expression of KiSS-1 protein was lower in HCC with metastasis and in clinical stage Ⅲ than that in those with non-metastasis, and in clinical stages Ⅰ and Ⅱ . It was also higher in the primary than in the metastasis lesions (P<0.01, respectively). The expression of MMP-9 was higher in tumors having peplos invasion and metastasis than in those with negative peplos invasion and non-metastasis. It was lower in the primary than the metastasis lesions (P<0. 01, respectively).Negative correlation between KiSS-1 and MMP-9 expression was found in HCC(r=- 0.340,P<0.01). Conclusions The imbalance between KiSS-1 and MMP-9 expression might play an important role in enhancing the invasive and metastatic capacity of HCC. Loss of KiSS-1 expression might predict an aggressive clinical behavior and was associated with metastatic potential in HCC.